Accessing European Investment in a Post Covid-19 World

Optimum in partnership with One Nucleus for ON Helix event held virtually in July 2020

An inspiring video Q&A interview where our Managing Director Mary Clark chaired a stellar panel discussion – “Accessing European Investment in a Post Covid-19 World” – joined by Maina Bhaman, Sofinnova Partners; Hakan Goker, M Ventures; Roel Bulthuis, INKEF Capital and Jonathan Tobin, Arix Bioscience.

ON Helix is fully committed to bring the insights and connections needed to understand innovation in translational research and support R&D companies in their current and future therapeutic and technology developments.